ID   H4AzC2
AC   CVCL_X358
DR   Wikidata; Q54872155
RX   PubMed=28957;
RX   PubMed=203590;
RX   PubMed=9745712;
CC   Selected for resistance to: ChEBI; CHEBI:63486; 8-azaguanine.
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
CC   Breed/subspecies: AxC; RS=RS:0000369.
DI   NCIt; C60416; Rat hepatocellular carcinoma
OX   NCBI_TaxID=10116; ! Rattus norvegicus (Rat)
OI   CVCL_4623 ! H4-II
SX   Male
CA   Cancer cell line
DT   Created: 17-07-14; Last updated: 10-09-24; Version: 8
//
RX   PubMed=28957; DOI=10.1016/0014-4827(78)90280-X;
RA   Leinwand L.A., Strair R.K., Ruddle F.H.;
RT   "Phenotypic and molecular expression of albumin in rat hepatoma x L
RT   cell hybrids.";
RL   Exp. Cell Res. 115:261-268(1978).
//
RX   PubMed=203590; DOI=10.1016/S0021-9258(17)34868-8;
RA   Strair R.K., Yap S.H., Nadal-Ginard B., Shafritz D.A.;
RT   "Identification of a high molecular weight presumptive precursor to
RT   albumin mRNA in the nucleus of rat liver and hepatoma cell line
RT   H4AZC2.";
RL   J. Biol. Chem. 253:1328-1331(1978).
//
RX   PubMed=9745712; DOI=10.1111/j.1432-0436.1998.00215.x;
RA   Zvibel I., Fiorino A.S., Brill S., Reid L.M.;
RT   "Phenotypic characterization of rat hepatoma cell lines and
RT   lineage-specific regulation of gene expression by differentiation
RT   agents.";
RL   Differentiation 63:215-223(1998).
//